Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique

Cytometry

Volumn 29, Issue 3, 1997, Pages 233-241

  Endl, Elmar ^a   Steinbach, Pia ^a   Knüchel, Ruth ^a   Hofstädter, Ferdinand ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

5 Bromodeoxyuridine; 7 Aminoactinomycin D; Cell cycle kinetics; Hoechst 33258; J82; Ki 67; MIB1; Multiparameter analysis; P120; Proliferation associated antigens; Tumor cells

Indexed keywords

KI 67 ANTIGEN;

ANTIBODY LABELING; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONOLAYER CULTURE; PRIORITY JOURNAL;

EID: 0030775143     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19971101)29:3<233::AID-CYTO6>3.0.CO;2-C     Document Type: Article

References (35)

1. Baisch H, Gerdes J: Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki-67 and propidium iodide: analysis by cytometry. Cell Tissue Kinet 20:387-391, 1987.
2. Beisker W, Dolbeare F, Gray JW: An improved immunocytochemical procedure for high sensitivity detection of incorporated bromodeoxyuridine. Cytometry 8:235-239, 1987.
3. Bocker T, Bittinger A, Wieland W, Büttner R, Fauser G, Hofstädter F, Rüschoff J: In vitro and ex vivo expression of nuclear proteins B23 and p120 in benign and malignant epithelial lesions of the prostate. Mod Pathol 8:226-231, 1995.
4. Böhmer RM: Flow cytometry cell cycle analysis using the quenching of 33258 Hoechst fluorescence by Bromodeoxyuridine incorporation. Cell Tissue Kinet 12:101-110, 1979.
5. Böhmer RM, Ellwart J: Cell cycle analysis by combining the 5-Bromodeoxy-uridine/33258 Hoechst technique with DNA-specific ethidium bromide staining. Cytometry 2:31-34, 1981.
6. Bolton WE, Mikulka WR, Healy CG, Schmittling RJ, Kenyon NS: Expression of proliferation associated antigens in the cell cycle of synchronized mammalian cells. Cytometry 13:117-126, 1994.
7. Braun N Papadopoulos T, Müller-Hermelink HK: Cell cycle dependent distribution of the proliferation associated Ki-67 antigen in human embryonic lung cells. Virchows Arch [B] 56:25-33, 1988.
8. Brown DC, Gatter KC: Monoclonal antibody Ki-67: its use in histopathology [invited review]. Histopathology 17:489-503, 1990.
9. Bruno S, Darzynkiewicz Z: Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 25:31-40, 1992.
10. Bruno S, Crissman HA, Bauer KD, Darzynkiewicz Z: Changes in cell nuclei during S-phase: progressive chromatin condensation and altered expression of the proliferation-associated nuclear proteins Ki-67, cyclin (PCNA), P105 and p34. Exp Cell Res 196:99-106, 1991.
11. Busch H: The final common pathway of cancer: presidential address. Cancer Res 50:4830-4838, 1990.
12. Cleaver JE: Thymidine metabolism and cell kinetics. In: Frontiers of Biology, Vol. 6, Neuberger A, Tatum EL (eds). North-Holland Publishing Company, Amsterdam, 1967, pp 92-94.
13. Duchrow M, Gerdes J, Schlüter C: The proliferation associated Ki-67 protein: definition in molecular terms [invited review]. Cell Prolif 27:235-242, 1994.
14. DuManoir S, Guillaud P, Seigneurin CE, Brugal G: Ki-67 labeling in postmitolic cells defines different Ki-67 pathways within the 2c compartment. Cytometry 12:455-463, 1991.
15. Fonagy A, Swiderski C, Ostrovsky AM, Bolton WE, Freeman JW: Effect of nucleolar p120 expression level on the proliferation capacity of breast cancer cells. Cancer Res 54:1859-1864, 1994.
16. Fonagy A, Swiderski C, Freeman JW: Altered transcription control is responsible for the increased level of proliferation-associated p120 in rapidly growing breast carcinoma. Int J Cancer 60:407-412, 1995.
17. Freeman JW, Busch RK, Gyorkey F, Ross BE, Busch H: Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase. Cancer Res 48:1244-1251, 1988.
18. Freeman JW, McGrath P, Bondada V, Selliah N, Ownby H, Maloney T, Busch RK, Busch H: Prognostic significance of proliferation associated nucleolar antigen p120 in human breast carcinoma. Cancer Res 51:1973-1978, 1991.
19. Gorczyca W, Bruno S, Melamed MR, Darzynkiewicz Z: Cell cycle-related expression of p120 nucleolar antigen in normal lymphocytes and in cells of HL60 an MOLT4 leukemic lines: effects of methotrexate, camptothecin and teniposide. Cancer Res 52:3491-3494, 1992.
20. Kaufman ER, Davidson RL: Biological and biochemical effects of Bromodeoxyuridine and Deoxycytidine on Syrian hamster melanoma cells. Somat Cell Genet 4:587-601, 1978.
21. Kubbies M, Rabinovitch PS: Flow cytometric analysis of factors which influence the BrdUrd-Hoechst quenching effect in cultivated human fibroblasts and lymphocytes. Cytometry 3:276-281, 1983.
22. Kubbies M, Hoehn H, Schindler D, Chen YC, Rabinovitch PS: Cell cycle analysis via BrdUrd/Hoechst flow cytometry: Principles and applications. In: Flow Cytometry: Advanced Research and Clinical Application, Vol. II, Yen A (ed). CRS-Press, Boca Raton, FL, 1989, pp 5-28.
23. Latt SA, George YS, Gray JW: Flow cytometric analysis of Bromodeoxyuridine-substituted cells stained with 33258 Hoechst. J Histochem Cytochem 25:927-934, 1977.
24. Lopez F, Belloc F, Lacombe F, Dumain P, Reiffers J, Bernard P, Boisseau MR: Modalities of synthesis of Ki-67 antigen during the stimulation of lymphocytes. Cytometry 12:42-49, 1991.
25. Ormerod MG, Kubbies M: Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label an Hoechst-propidium iodide stain. Cytometry 13:678-685, 1992.
26. O'Toole C, Price ZH, Ohnuki Y, Unsgaard B: Ultrastructure, karyology and immunology of a cell line originated from a human transitional cell carcinoma. Br J Cancer 38:64-76, 1978.
27. Overton WR: Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 9:619-626, 1988.
28. Perlaky L, Valdez BC, Busch RK, Larson RG, Jhiang SM, Zhang WW, Brattain M, Busch H: Increased growth of NIH/3T3 cells by transfection with human p120 complementary DANN and inhibition by a p120 antisense construct. Cancer Res 52:428-436, 1992.
29. Rabinovitch PS, Torres RM, Engel D: Simultaneous cell cycle analysis and two-color surface immunofluorescence using 7-amino-actinomycin D and single laser excitation: application to study of cell activation and the cell cycle of murine LY-1 B cells. J Immunol 136:2769-2775, 1986.
30. Rüschoff J, Fauser G, Knüchel R, Hofstädter F: AgNOR quantification with special reference to staining patterns. Zentralbl Pathol 140:23-30, 1994.
31. Schmidt W: Comment on R.A. White's v-function. Cytometry 24:289-291, 1996.
32. Ueki T, Nakayama Y, Sugao Y, Kohno K, Matsuo K, Sugimoto Y, Yamada Y, Kuwano M, Tsuneyoshi M: Significance of the expression of proliferation-associated nucleolar antigen p120 in human colorectal tumors. Hum Pathol 28:74-79, 1997.
33. Van Bockstaele DR, Lan J, Snoeck HW, Korthout ML, De Bock RF, Peetersmans ME: Aberrant Ki-67 expression in normal bone marrow revealed by multiparameter flow cytometric analysis. Cytometry 12:50-63, 1991.
34. Van Dierendonck JH, Keijzer R, Van de Velde CJH, Cornelisse CJ: Nuclear distribution of the Ki-67 antigen during the cell cycle: Comparison with growth fraction in human breast cancer cells. Cancer Res 49:2999-3006, 1989.
35. Verheijen R, Kuijpers HJH, Schlingemann RO, Boehmer ALM, vanDriel R, Brakenhoff GJ, Ramaekers FCS: Ki-67 detects a nuclear matrix-associated proliferation related antigen: intracellular localization during interphase. J Cell Sci 92:123-130, 1989.